Hope for RNAi and Pharmaceutical companies?
نویسندگان
چکیده
منابع مشابه
Good publication practice for pharmaceutical companies.
Guidelines on Good Publication Practice (GPP) for pharmaceutical companies are presented. The aim of the guidelines is to ensure that clinical trials sponsored by pharmaceutical companies are published in a responsible and ethical manner. The guidelines cover companies' responsibility to an endeavour to publish results of all studies, companies' relations with investigators, measures to prevent...
متن کامل[Clinical trials, pharmaceutical companies and clinical practice].
INTRODUCCIÓN Los médicos y la industria farmacéutica comparten el objetivo del progreso en el conocimiento científico; sin embargo, el principal interés del médico es proporcionar a sus pacientes el mejor tratamiento posible, mientras que el principal interés de la industria es vender su producto. La industria farmacéutica colabora en el desarrollo de importantes avances en medicina y tecnologí...
متن کاملMedical journals and pharmaceutical companies: uneasy bedfellows.
One of my first experiences of the relation between medical journals and pharmaceutical companies occurred in the early 1980s after the BMJ had published papers suggesting that a new non-steroidal anti-inflammatory drug, benoxaprofen, might have serious side effects. We were visited by three stern men from Eli Lilly, the makers of the drug. Tony Smith, the deputy editor, conducted the meeting a...
متن کاملBuyouts of Indian Pharmaceutical Companies by Multinational Pharmaceutical Companies: An Issue of Concern
healthcare and Ranbaxy have been bought by Abbott and Daiichi Sankyo, respectively.[3] Cipla, an indigenous company, lone with a market share of about 5.4% tops the list of top 10 companies in India. The increasing presence of foreign companies among the top pharmaceutical companies in India is may be due to a few buyouts which happened in the recent past. Daiichi Sankyo, a leading Japanese pha...
متن کاملVirtual pharmaceutical companies: collaborating flexibly in pharmaceutical development.
Research and development (R&D) collaborations represent one approach chosen by the pharmaceutical industry to tackle current challenges posed by declining internal R&D success rates and fading of the blockbuster model. In recent years, a flexible concept to collaborate in R&D has emerged: virtual pharmaceutical companies (VPCs). These differ from other R&D companies, such as biotech start-ups, ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Drug Delivery System
سال: 2004
ISSN: 1881-2732,0913-5006
DOI: 10.2745/dds.19.343